Laura J Rau, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 24 Deneveu Cir, Fond Du Lac, WI 54935 Phone: 920-924-9585 |
Wisconsin Vision, Inc Optometrist Medicare: Medicare Enrolled Practice Location: 459 W Johnson St, Fond Du Lac, WI 54935 Phone: 920-922-5990 Fax: 920-922-7482 |
Dr. Benjamin R Scoresby, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 421 Camelot Dr, Fond Du Lac, WI 54935 Phone: 920-926-8472 Fax: 920-926-8391 |
J. Brian Conran, O.d., S.c. Optometrist Medicare: Medicare Enrolled Practice Location: 110 E Division St, Fond Du Lac, WI 54935 Phone: 920-922-5430 Fax: 920-922-5478 |
Family Focus Eye Care Optometrist - Corneal and Contact Management Medicare: Medicare Enrolled Practice Location: 355 N Peters Ave Ste 1, Fond Du Lac, WI 54935 Phone: 920-922-7121 Fax: 920-922-5666 |
Jessica Kulick, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 355 N Peters Ave, Fond Du Lac, WI 54935 Phone: 920-922-7121 |
Dr. Julie M Henry, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 210 Wisconsin American Dr, Fond Du Lac, WI 54935 Phone: 920-907-7000 Fax: 920-907-7012 |
Cortney D Birschbach, OD Optometrist - Corneal and Contact Management Medicare: Accepting Medicare Assignments Practice Location: 355 N Peters Ave, Fond Du Lac, WI 54935 Phone: 920-922-7121 |
Tristan G Brown, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 421 Camelot Dr, Fond Du Lac, WI 54935 Phone: 920-926-8472 |
Dr. Daniel James Kierstead, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 377 N Rollings Meadows Dr, Fond Du Lac, WI 54937 Phone: 920-921-8022 Fax: 920-921-8254 |
W P Zuege,o.d., S.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 110 E Division St, Fond Du Lac, WI 54935 Phone: 920-922-5430 Fax: 920-922-5478 |
Dr. Carin M Lacount, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 616 W Johnson St, Fond Du Lac, WI 54935 Phone: 920-921-8290 Fax: 920-921-7112 |
Dr. W P Zuege, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 110 E Division St, Fond Du Lac, WI 54935 Phone: 920-922-5430 |
Pamela G Brown, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 421 Camelot Dr, Fond Du Lac, WI 54935 Phone: 920-926-8472 |
Dr. David Brian Hammes, O.D. Optometrist - Corneal and Contact Management Medicare: Accepting Medicare Assignments Practice Location: 355 N Peters Ave, Fond Du Lac, WI 54935 Phone: 920-922-7121 Fax: 920-922-5666 |
George Boling, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 835 W Johnson St, Spc. C07c Forest Mall, Fond Du Lac, WI 54935 Phone: 920-906-9489 |
Dr. Mark Edward Veth, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 437 N Pioneer Rd, Fond Du Lac, WI 54935 Phone: 920-923-0000 Fax: 920-923-5601 |
Ssm Health Fond Du Lac Regional Clinic Optometrist Medicare: Not Enrolled in Medicare Practice Location: 420 E Division St, Fond Du Lac, WI 54935 Phone: 920-923-7400 |
Jack Lund Optometrist Medicare: Medicare Enrolled Practice Location: 459 W Johnson St, Fond Du Lac, WI 54935 Phone: 920-922-5990 |
Dr. J Brian Conran, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 110 E Division St, Fond Du Lac, WI 54935 Phone: 920-922-5430 |
News Archive
A child's ability to succeed academically is one of the strongest determinants of his or her future quality of life. In particular, it has been directly linked to overall longevity and several other critical health outcomes.
Women with symptoms of serious mental illness are significantly less likely to receive three routine cancer screenings - Pap tests, mammograms and clinical breast exams - than women in the general population, despite being at elevated risk for medical comorbidities and early death, a new study indicates.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has held its second meeting with the Australian Therapeutic Goods Administration ("TGA") to discuss milestones for approval of PV-10 for treatment of metastatic melanoma. The TGA is the part of the Australian Government's Department of Health and Ageing responsible for the assessment, approval and monitoring of therapeutic goods available in Australia. The initial meeting with the TGA was held in October 2008.
Acorda Therapeutics, Inc. today announced plans to initiate a Phase 1 single-dose clinical trial of the Company's compound, Glial Growth Factor 2 (GGF2), in patients with heart failure in mid-2010, based on an IND filed with the U.S. Food and Drug Administration (FDA) on March 19, 2010. GGF2 has been shown to protect heart muscle and restore cardiac function in preclinical models of heart failure, myocardial infarction and cardiotoxicity.
› Verified 9 days ago